This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Levitz, S M Search for Related Content PubMed PubMed Citation Articles by Levitz, S M

 Previous Article  |  Next Article 

Infect Immun. 1991 October; 59(10): 3393-3397

Activation of human peripheral blood mononuclear cells by interleukin-2 and granulocyte-macrophage colony-stimulating factor to inhibit Cryptococcus neoformans.

Evans Memorial Department of Clinical Research, University Hospital, Boston University Medical Center, Massachusetts 02118.

ABSTRACT

The abilities of selected cytokines to activate human peripheral blood mononuclear cells (PBMC) to inhibit and kill the opportunistic fungus Cryptococcus neoformans were studied. PBMC were cultured for 7 days in cell wells containing no cytokines, tumor necrosis factor (TNF), gamma interferon (IFN-gamma), 1,25-dihydroxycholecalciferol (vitamin D3), granulocyte-macrophage colony-stimulating factor (GM-CSF), or interleukin-2 (IL-2) and were then challenged for 24 h with a fixed number of CFU of C. neoformans. The number of CFU increased in wells containing no cytokines, TNF, IFN-gamma, or vitamin D3 and remained about the same in wells containing GM-CSF. In contrast, the number of CFU in wells containing IL-2-stimulated PBMC decreased, suggesting fungicidal activity. Optimal conditions for IL-2 stimulation included a minimum of 5 days of incubation of PBMC with IL-2, a concentration of 100 U of IL-2 per ml, and a high ratio of effectors to fungi. Separation of IL-2-stimulated PBMC based upon their adherence to plastic revealed that antifungal activity resided in the nonadherent fraction. These data demonstrate that IL-2 and GM-CSF are capable of stimulating PBMC-mediated antifungal activity and suggest that these cytokines may play physiological or pharmacological roles in host defenses against cryptococcosis.

This article has been cited by other articles:

• Osterholzer, J. J., Curtis, J. L., Polak, T., Ames, T., Chen, G.-H., McDonald, R., Huffnagle, G. B., Toews, G. B. (2008). CCR2 Mediates Conventional Dendritic Cell Recruitment and the Formation of Bronchovascular Mononuclear Cell Infiltrates in the Lungs of Mice Infected with Cryptococcus neoformans. J. Immunol. 181: 610-620 [Abstract] [Full Text]  
• Zheng, C. F., Jones, G. J., Shi, M., Wiseman, J. C. D., Marr, K. J., Berenger, B. M., Huston, S. M., Gill, M. J., Krensky, A. M., Kubes, P., Mody, C. H. (2008). Late Expression of Granulysin by Microbicidal CD4+ T Cells Requires PI3K- and STAT5-Dependent Expression of IL-2R{beta} That Is Defective in HIV-Infected Patients. J. Immunol. 180: 7221-7229 [Abstract] [Full Text]  
• Pericolini, E., Cenci, E., Gabrielli, E., Perito, S., Mosci, P., Bistoni, F., Vecchiarelli, A. (2008). Indinavir influences biological function of dendritic cells and stimulates antifungal immunity. J. Leukoc. Biol. 83: 1286-1294 [Abstract] [Full Text]  
• Wormley, F. L. Jr., Perfect, J. R., Steele, C., Cox, G. M. (2007). Protection against Cryptococcosis by Using a Murine Gamma Interferon-Producing Cryptococcus neoformans Strain. Infect. Immun. 75: 1453-1462 [Abstract] [Full Text]  
• Gyetko, M. R., Sud, S., Chen, G.-H., Fuller, J. A., Chensue, S. W., Toews, G. B. (2002). Urokinase-Type Plasminogen Activator Is Required for the Generation of a Type 1 Immune Response to Pulmonary Cryptococcus neoformans Infection. J. Immunol. 168: 801-809 [Abstract] [Full Text]  
• Vazquez, N., Walsh, T. J., Friedman, D., Chanock, S. J., Lyman, C. A. (1998). Interleukin-15 Augments Superoxide Production and Microbicidal Activity of Human Monocytes against Candida albicans. Infect. Immun. 66: 145-150 [Abstract] [Full Text]